The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Albendazole (Brand name: Albenza®)
- Manufactured by
FDA-approved indication: Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium.
National Library of Medicine Drug Information Portal